Potassium Ferrate Hemostatic Sealant-Assisted Early Radial Hemostasis After Transradial Coronary Angiography and PCI

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alberta

About this trial

This study aims to evaluate patients undergoing coronary angiography by comparing the use of Potassium Ferrate Hemostatic Sealant (PFHS) in addition to the standard of care (SOC) pneumatic radial compression device versus SOC alone. The objective is to determine whether the addition of PFHS reduces the time to successful deflation and removal of the radial compression device.

Eligibility criteria

Qualifiers

Age ≥ 18 years • Undergoing trans radial coronary angiography with or without PCI

Radial 6Fr Prelude sheath used for the procedure

Planned use of Inflation band (Sunny Medical) radial compression device for hemostasis

Able to provide informed consent

Disqualifiers

On a GPIIB/IIIA inhibitor

Known hypersensitivity to device materials

Infection or serious skin disease at puncture site

Abnormal collateral circulation test / insufficient dual arterial supply

Trial design

Treatments tested in this trial

  • Experimental: PFHS + pneumatic radial compression device
  • Pneumatic radial compression device alone.

Treatment groups

300 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators